Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express

03/16

Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.

The agenda includes:

• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. • Considering a recommendation on the payment of a final dividend, if any.

The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).

No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1175773288"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175773288\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175773288?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175773288","market":"us","top_or_hot":-1,"title":"Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.</p>\n<p>The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).</p>\n<p>No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.</p>\n<p>The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).</p>\n<p>No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03869","symbol_name":"弘和仁爱医疗","start_time":0,"source_url":"","article_id":"1175773288","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175773288","pubTimestamp":1773653008,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong. The agenda includes: • Reviewing and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03869":"弘和仁爱医疗"},"translate_title":"中华医院股份有限公司(03869)定于2026年3月26日召开董事会批准2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03869":1},"content_text":"Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.\nThe agenda includes:\n• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation on the payment of a final dividend, if any.\nThe announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).\nNo additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}